HEILONGJIANG ZBD PHARMACEUTICAL CO., LTD.

Andere Sprachen Heilongjiang ZBD Pharmaceutical Co., Ltd.

Aktien

A1436Y

CNE100002219

603567

Schlusskurs Shanghai S.E. Andere Börsenplätze 00:00:00 07.06.2024			% 5 Tage	% 1. Jan.
12,12 ^CNY	+0,25 %		-1,78 %	-0,33 %

27.05.	ZBD Pharma erhält in China die Zulassung für Magensäure hemmende Tabletten	MT
07.05.	China erteilt Arzneimittelzulassung für injizierbares Anti-Epilepsie-Mittel von ZBD Pharma	MT

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

ZBD Pharma Gets China Approval for Gastric Acid Inhibiting Tablets	27.05.
China Grants Drug Registration Approval for ZBD Pharma's Anti-Epilepsy Injectable	07.05.
Heilongjiang ZBD Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29.04.
Heilongjiang ZBD Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	29.04.
ZBD Pharma Gets Nod for Tofacitinib Citrate Tablets	21.02.
Heilongjiang ZBD Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27.10.23
HeiLongJiang ZBD Pharma Registers Osteoarthritis Drug	26.09.23
Heilongjiang ZBD Pharmaceutical Co., Ltd.(XSSC:603567) added to S&P Global BMI Index	18.09.23
Heilongjiang ZBD Pharmaceutical Co., Ltd.(XSSC:603567) added to FTSE All-World Index	18.09.23
Heilongjiang ZBD Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23.08.23
Tranche Update on Heilongjiang ZBD Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 10, 2022.	11.05.23
Heilongjiang ZBD Pharmaceutical Co., Ltd.'s Equity Buyback announced on June 10, 2022 has closed with 2,560,300 shares, representing 0.27% for CNY 30 million.	10.05.23
Heilongjiang ZBD Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28.04.23
Heilongjiang ZBD Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	28.04.23
Tranche Update on Heilongjiang ZBD Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 10, 2022.	05.04.23
Tranche Update on Heilongjiang ZBD Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 10, 2022.	04.01.23
Heilongjiang ZBD Pharmaceutical to Tie Up With Kangyue Technology on Medicine Supplies	06.12.22
Heilongjiang ZBD Gets Approval for Traditional Medicine Product	04.11.22
Heilongjiang ZBD’s Anti-Pulmonary Fibrosis Drug Gets U.S. Patent	02.11.22
Heilongjiang ZBD Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27.10.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Heilongjiang ZBD Pharmaceutical Co., Ltd.

Aktien

A1436Y

CNE100002219

603567

Andere Sprachen

Filter